期刊文献+

基于Hsp90 ATPase活性的抑制剂筛选模型研究 被引量:4

Study on a Screening Model for Inhibitor of Hsp90 ATPase Activity
下载PDF
导出
摘要 热休克蛋白90(Heat shock protein,Hsp90)作为分子伴侣,参与调控肿瘤细胞多条信号通路,对肿瘤细胞生长有重要作用.以pGEX-4T-1为载体,构建了Hsp90表达载体于宿主大肠杆菌中表达.通过孔雀绿磷钼酸铵-无机磷检测法,测定异源表达的Hsp90 ATPase活性.实验得出Hsp90对ATP的米氏常数(Km)为369.1μmol/L,在Hsp90和ATP浓度分别为0.18,1 mmol/L时转换效率常数(kcat)为1.6 min-1,最大反应速率(Vmax)为1.0μmol/(L.min).基于该方法,建立Hsp90 ATPase活性抑制剂筛选模型,以Geldanamycin和Radicicol为阳性对照,发现Rifamycin、Rugulosin及My-coE也有较强的Hsp90 ATPase抑制活性.该方法可用于筛选抗肿瘤候选化合物的研究,同时也可为具有ATPase活性蛋白的抑制剂筛选提供参考. As a molecular chaperone,Hsp90 regulates multiple signaling pathways of tumor cells and plays an important role in the growth of tumor cells.In this paper,recombinant vector of Hsp90-pGEX-4T-1 was constructed for Expression of Hsp90,and fusion protein was expressed in E.coli(DE3).A colorimetric assay for inorganic phosphate which based on the formation of a phosphomolybdate complex and subsequent reaction with malachite green were used for determination of Hsp90 ATPase activity.The Km for ATP determined in this assay was 369.1 μmol/L,the Vm and kcat were 1.0 μmol/(L·min) and 1.6 min-1,when the concentration of Hsp90 and ATP were 0.18 μmol/L and 1 mmol/L respectively.Based on this method,a screening model for inhibitor of Hsp90 ATPase activity was established.Later study found that Rifamycin,Rugulosin and MycoE showed inhibition of Hsp90 ATPase activity,with the IC50 values were 18.04,22.77 and 38.45 μmol/L,but the IC50 valus were higher than the IC50 of GA and RDC.This method can not only be used to discover anti-cancer drug,but also to screen inhibitor of protein with ATPase activity.
出处 《厦门大学学报(自然科学版)》 CAS CSCD 北大核心 2010年第5期711-716,共6页 Journal of Xiamen University:Natural Science
基金 国家自然科学基金(30873148 30973566) 国家高技术研究发展计划(863计划)项目(2007AA091503) 厦门市科技计划项目(3502Z20093014) 福建省自然科学基金(2010J01227)
关键词 PGEX-4T-1 HSP90 ATPASE活性 pGEX-4T-1 Hsp90 ATPase activity
  • 相关文献

参考文献16

  • 1Wu W C,Kao Y H,Hu P S,et al.Geldanamycin,a Hsp90 inhibitor,attenuates the hypoxia-induced vascular endothelial growth factor expression in retinal pigment epithelium cells in vitro[J].Exp Eye Res,2007,85(5):721-731.
  • 2Chen B,Zhong D,Monteiro A.Comparative genomics and evolution of the Hsp90 family of genes across all kingdoms of organisms[J].BMC Genomics,2006,7:156.
  • 3Taldone T,Gozman A,Maharaj R,et al.Targeting Hsp-90:small-molecule inhibitors and their clinical development[J].Curr Opin Pharmacol,2008,8(4):370-374.
  • 4Li Y,Zhang T,Schwartz S J,et al.New developments in Hsp90 inhibitors as anti-cancer therapeutics:mechanisms,clinical perspective and more potential[J].Drug Resist Updat,2009,12(1/2):17-27.
  • 5Georgakis G V,Li Y,Rassidakis G Z,et al.The Hsp90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression[J].Exp Hematol,2006,34(12):1670-1679.
  • 6Muranaka K,Sano A,Ichikawa S,et al.Synthesis of H-sp90 inhibitor dimers as potential antitumor agents[J].Bioorg Med Chem,2008,16(11):5862-5870.
  • 7Panaretou B,Prodromou C,Roe S M,et al.ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo[J].EMBO J,1998,17(16):4829-4836.
  • 8Jez J M,Chen J C,Rastelli G,et al.Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90[J].Chem Biol,2003,10(4):361-368.
  • 9Chang L,Bertelsen E B,Wisen S,et al.High-throughput screen for small molecules that modulate the ATPase activity of the molecular chaperone DnaK[J].Anal Biochem,2008,372(2):167-176.
  • 10Rowlands M G,Newbatt Y M,Prodromou C,et al.H-igh-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity[J].Anal Biochem,2004,327(2):176-183.

二级参考文献2

共引文献5

同被引文献13

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部